How exercise protects the brain against Parkinson's disease

Physical exercise triggers a chemical conversation between muscle and brain that slows Parkinson's disease progression. When muscle contracts, it secretes molecules called exerkines—including BDNF, IGF-1, irisin, and cathepsin B—that travel to the nervous system and protect dopaminergic neurons against α-synuclein accumulation, the disease's pathological hallmark. Clinical trials confirm that aerobic, resistance, and multimodal exercise programs improve gait, balance, cognition, and quality of life, with progressive strength and balance training showing the greatest motor benefits. At the mechanistic level, these exerkines deploy anti-inflammatory, antioxidant, and mitochondrial regulatory pathways that sustain neuronal survival and synaptic plasticity. For the longevity reader, the message is direct: exercise is today's most potent pharmaceutical against neurodegeneration, and its power lies in reactivating muscle as an active endocrine organ, not merely as a mechanical structure.